trending Market Intelligence /marketintelligence/en/news-insights/trending/xAVoGdvDhDEuMxQ-WsZIww2 content esgSubNav
In This List

Rexahn Pharmaceuticals transfers listing to Nasdaq Capital Market

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Rexahn Pharmaceuticals transfers listing to Nasdaq Capital Market

Rexahn Pharmaceuticals Inc. said it will transfer its listing from the NYSE American exchange to the Nasdaq Capital Market.

The Rockville, Md.-based biotechnology company, which develops treatments for cancer, expects to start trading on Nasdaq under the symbol REXN on or about June 10.

The company's stock will continue to trade on the NYSE American under the symbol RNN until the transfer is completed.